Evidence map›Paper›PMID 36338079›Full record

ArticleFrontiers in microbiology2022

Critical control point-based assessment and intervention of ochratoxin A risk in Angelicae Gigantis Radix production.

Juil Kim, Tae Jin An, Yuseok Moon

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Juil KimLaboratory of Mucosal Exposome and Biomodulation, Department of Integrative Biomedical Sciences and Biomedical Research Institute, Pusan National University, Yangsan, South Korea.
Tae Jin AnDepartment of Herbal Crop Research, National Institute of Horticultural and Herbal Science (NIHHS), Eumseong, South Korea.
Yuseok MoonLaboratory of Mucosal Exposome and Biomodulation, Department of Integrative Biomedical Sciences and Biomedical Research Institute, Pusan National University, Yangsan, South Korea.
Pusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Improperly practiced postharvest procedures can pose mycotoxin-related risks during medicinal herb production. As a health food material with pharmacological activities, Angelicae Gigantis Radix (AGR) has been extensively used in oriental medicine or functional foods. Compared with the official protocol, conventional practices were investigated for provisional critical control points (CCPs) in terms of ochratoxin A (OTA) contamination. Conventional practices include field-drying, which was associated with increased fungal exposure. Compared with conventional methods, the washing process in the official protocol was not advantageous for reducing OTA contamination in final products. Instead, drying was examined to assess the fungal growth risk during AGR production. To reduce the energy cost, product overload and shortened drying time could lead to failure in controlling fungal overgrowth and subsequent OTA production. In particular, inner parts of the load contained a higher OTA content than outer parts close to the heat outlet of the dryer. Improper thermal drying of loads allowed the growth of ochratoxigenic species during AGR production. Collectively, non-field-drying and optimally loaded thermal drying are easy preventive actions in key CCPs that need to be well maintained to attenuate any further microbial risk. These assessments provide insights into good practice-based mycotoxin risk management in producing herbal medicinal crops and new cost-efficient appropriate interventions for small-scale farms.

Indexed as

Angelicae Gigantis Radixcritical control pointsmycotoxinspostharvestthermal drying

Identifiers

PMID36338079
PMCPMC9633853
OpenAlexW4306951369

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.